| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, Hospital La Princesa, Universidad Autónoma de Madrid, Madrid, Spain
Address correspondence and reprint requests to Emilio Matute, MD, DEAA, Department of Anesthesia, Hospital La Princesa, Calle Diego de León, 62, 28006 Madrid, Spain. Address e-mail to med009569{at}nacom.es
We studied 120 patients scheduled for elective major thoracic or abdominal surgery, randomized into 2 groups: a Sevoflurane group (n = 63) and a Remifentanil group (n = 57). Heart rate (HR) and mean arterial pressure (MAP) are indicative of sympathetic response to surgical stress. A positive response was defined as a 15% increase in the HR and MAP above baseline mea-surements. When a positive response occurred, in the Sevoflurane group we administered a bolus dose of 8% sevoflurane (fresh gas flow 6 L/min) and in the Remifentanil group, an IV bolus dose of remifentanil 1 µg · kg-1 · min-1, which was maintained until MAP and HR returned to baseline measurements (effective bolus). If, after a bolus dose, a decrease in MAP and/or HR of >15% occurred with respect to baseline values, the response was considered to be excessive. The bolus dose was ineffective in 4.8% of the responses in the Sevoflurane group and in 17.8% of the responses in the Remifentanil group (P < 0.05). In the Sevoflurane group, an excessive effect occurred in 12% of responses, and in 26.7% in the Remifentanil group (P < 0.05). An inhalation bolus of sevoflurane seems to be more effective than an IV remifentanil bolus during maintenance, with more effective control of hemodynamic responses to surgical stress.
IMPLICATIONS: We compared an inhalation bolus of sevoflurane with remifentanil for managing hemodynamic responses to major abdominal or thoracic surgery. This prospective, randomized trial demonstrated better results with sevoflurane.
This article has been cited by other articles:
![]() |
B. Steinlechner, M. Dworschak, B. Birkenberg, T. Lang, A. Schiferer, A. Moritz, B. Mora, and A. Rajek Low-dose remifentanil to suppress haemodynamic responses to noxious stimuli in cardiac surgery: a dose-finding study Br. J. Anaesth., May 1, 2007; 98(5): 598 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Cucchiaro, S. D. Markowitz, R. Kaye, N. S. Adzick, R. S. Litman, C. A. Stanley, and M. F. Watcha Blood Glucose Control During Selective Arterial Stimulation and Venous Sampling for Localization of Focal Hyperinsulinism Lesions in Anesthetized Children Anesth. Analg., October 1, 2004; 99(4): 1044 - 1048. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. C. De Baerdemaeker, M. M. R. F. Struys, S. Jacobs, N. M. M. Den Blauwen, G. R. P. J. Bossuyt, P. Pattyn, and E. P. Mortier Optimization of desflurane administration in morbidly obese patients: a comparison with sevoflurane using an 'inhalation bolus' technique Br. J. Anaesth., November 1, 2003; 91(5): 638 - 650. [Abstract] [Full Text] [PDF] |
||||
|